Study of Tesevatinib Monotherapy in Patients With Recurrent Glioblastoma
Clinical trial NCT02844439 · COMPLETED
Trial details
- NCT number
- NCT02844439
- Sponsor
- Kadmon Corporation, LLC
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-06-01
- Primary completion
- 2020-04-30
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.